Robinetinidol Diversity IV-PR-B

Vaccinium corymbosum

Blueberry

Tier IVRobinetinidol Diversity

Target Trait

2.74×

fold-change

Robinetinidol unit PA structural diversity index

Technical Specifications

SKU

SS-F-AST-710

Genomic Edits

GC Content

49.3%

Construct Length

4,054 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

Polyphenol-astringency axis

IFI Score

274

Pathway Edits

CYP82D1 overexpression for 7,3,4,5-tetrahydroxyflavane ring modification and robinetinidol-type unit biosynthesis
ANR-alt alternative anthocyanidin reductase variant for regiochemically distinct substrate acceptance
LAR co-expression (leucoanthocyanidin reductase) for PA chain extension with robinetinidol units
TT12 vacuolar transporter upregulation for robinetinidol-containing PA sequestration
Protoplast PEG-fusion transient and stable integration protocol
Enhanced flux via 5'UTR synthetic leader sequence optimization

Key Interventions

CYP82D1 P450-mediated 7,3,4,5-tetrahydroxyflavane modification for robinetinidol unit biosynthesisANR-alt regiochemical flexibility for unusual leucoanthocyanidin substrate incorporationLAR/TT12 PA chain extension and vacuolar sequestration for robinetinidol diversityPEG-4000 mediated membrane fusion at 37°CVariant B enhanced: iterative codon optimization for host-matched expression

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

274

IFI-F

—

Use Case

Industrial rare-unit PA ingredient production, premium specialty polyphenol formulation, complex astringency ingredient manufacturing. Enhanced variant for premium or research-grade applications requiring peak astringency fidelity.

License

$4049 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Astringency · IFI-A All Modalities